Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.
Saved in:
| Title: | Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial. |
|---|---|
| Authors: | Tronieri JS; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA, jena.tronieri@pennmedicine.upenn.edu., Fabricatore AN; Novo Nordisk Inc., Plainsboro, New Jersey, USA., Wadden TA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Auerbach P; Novo Nordisk A/S, Søborg, Denmark., Endahl L; Novo Nordisk A/S, Søborg, Denmark., Sugimoto D; Cedar Crosse Research Center, Chicago, Illinois, USA., Rubino D; Washington Center for Weight Management and Research, Arlington, Virginia, USA. |
| Source: | Obesity facts [Obes Facts] 2020; Vol. 13 (6), pp. 572-583. Date of Electronic Publication: 2020 Nov 16. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 101469429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1662-4033 (Electronic) Linking ISSN: 16624025 NLM ISO Abbreviation: Obes Facts Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1662-4033 |
|---|---|
| DOI: | 10.1159/000511130 |
